Babar, Z., & Areesha Babar. (2025). FDA’s New Approval: Kisunla (Donanemab-Azbt) - A Major Breakthrough in Alzheimer’s Care. Journal of the Pakistan Medical Association, 75(07), 1156–1156. https://doi.org/10.47391/JPMA.21951